Hepatic lipase deficiency

Critical Reviews in Clinical Laboratory Sciences

Volumn 35, Issue 6, 1998, Pages 547-572

  Connelly, Philip W ^a,b,d   Hegele, Robert A ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d J Alick Little Lipid Res Laboratory   (Canada)

Author keywords

Hepatic lipase deficiency; Hepatocytes; Hydrolyzes phospholipids; Plasma lipoproteins; Triglycerides

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; CHOLESTEROL ESTER; CHYLOMICRON; ESTROGEN; HEPARIN; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

ADRENAL GLAND; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONSENSUS SEQUENCE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME RELEASE; GLYCOSYLATION; HUMAN; HYDROLYSIS; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER CELL; OVARY; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW;

ANIMALS; APOLIPOPROTEINS B; HEART DISEASES; HUMANS; HYPERLIPIDEMIAS; LIPASE; LIPOPROTEINS; LIPOPROTEINS, VLDL; LIVER; MACROPHAGES; PEDIGREE; VARIATION (GENETICS);

EID: 0032442084     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408369891234273     Document Type: Review

References (62)

1. Bruce C, Chouinard RA Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998; 18: 297-330.
2. Stahnke G, Sprengel R, Augustin J, et al. Human hepatic triglyceride lipase: cDNA cloning, amino acid sequence and expression in a cultured cell line. Differentiation 1987; 35: 45-52.
3. Komaromy MC, Schotz MC. Cloning of rat hepatic lipase cDNA: evidence for a lipase gene family. Proc Natl Acad Sci USA 1987; 84: 1526-30.
4. Hide WA, Chan L Li WH. Structure and evolution of the lipase superfamily. J Lipid Res 1992; 33: 167-78.
5. Wolle J, Jansen H, Smith LC, et al. Functional role of N-linked glycosylation in human hepatic lipase: asparagine-56 is important for both enzyme activity and secretion. J Lipid Res 1993; 34: 2169-76.
6. Hill JS, Davis RC, Yang D, et al. Human hepatic lipase subunit structure determination. J Biol Chem 1996; 271: 22931-6.
7. Hill JS, Davis RC, Yang D, et al. Hepatic lipase: high-level expression and subunit structure determination. Methods Enzymol 1997; 284: 232-46.
8. Nilsson A, Landin B Schotz MC. Hydrolysis of chylomicron arachidonate and linoleate ester bonds by lipoprotein lipase and hepatic lipase. J Lipid Res 1987; 28: 510-7.
9. Thuren T, Weisgraber KH, Sisson P, et al. Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins. Biochemistry 1992; 31: 2332-8.
10. Jackson RL. Lipoprotein lipase and hepatic lipase. Boyer, P. Ed. The Enzymes., vol. 16. New York: Academic Press; 1983; p. 141-81.
11. Persoon NL, Hulsmann WC Jansen H. Localization of the salt-resistant heparin-releasable lipase in the rat liver, adrenal and ovary. Eur J Cell Biol 1986; 41: 134-7.
12. Laposata EA, Laboda HM, Glick JM, et al. Hepatic lipase. Synthesis, processing, and secretion by isolated rat hepatocytes. J Biol Chem 1987; 262: 5333-8.
13. Breedveld B, Schoonderwoerd K, Verhoeven AJ, et al. Hepatic lipase is localized at the parenchymal cell microvilli in rat liver. Biochem J 1997; 321: 425-30.
14. Persoon NL, Sips HJ, Hulsmann WC, et al. Monoclonal antibodies against salt-resistant rat liver lipase. Cross-reactivity with lipases from rat adrenals and ovaries. Biochim Biophys Acta 1986; 875: 286-92.
15. Hixenbaugh EA, Sullivan TRJ, Strauss JF, Hepatic lipase in the rat ovary. Ovaries cannot synthesize hepatic lipase but accumulate it from the circulation. J Biol Chem 1989; 264: 4222-30.
16. Verhoeven AJ, Jansen H. Hepatic lipase mRNA is expressed in rat and human steroidogenic organs. Biochim Biophys Acta 1994; 1211: 121-4.
17. Verhoeven AJ, Jansen H. The rat hepatic lipase gene is expressed into two different proteins in liver, adrenals and ovaries. Z Gastroenterol 1996; 34(Suppl): 54-55.
18. Murtomaki S, Tahvanainen E, Antikainen M, et al. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol 1997; 17: 1879-84.
19. Guerra R, Wang J, Grundy SM, et al. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 1997; 94: 4532-7.
20. Jansen H, Verhoeven AJ, Weeks L, et al. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 1997; 17: 2837-42.
21. Tahvanainen E, Syvanne M, Frick MH, et al. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. J Clin Invest 1998; 101: 956-60.
22. Vega GL, Clark LT, Tang A, et al. Hepatic lipase activity is lower in African-American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 1998; 39: 228-32.
23. Martin GA, Busch SJ, Meredith GD, et al. Isolation and cDNA sequence of human postheparin plasma hepatic triglyceride lipase. J Biol Chem 1988; 263: 10907-14.
24. Nie L, Niu S, Vega GL, et al. Three polymorphisms associated with low hepatic lipase activity are common in African-Americans. J Lipid Res 1998; 39: 1900-3.
25. Breckenridge WC, Little JA, Alaupovic P, et al. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 1982; 45: 161-79.
26. Auwerx JH, Babirak SP, Hokanson JE, et al. Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family. Am J Hum Genet 1990; 46: 470-7.
27. Brand K, Dugi KA, Brunzell JD, et al. A novel A→G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J Lipid Res 1996; 37: 1213-23.
28. Hegele RA, Little JA Connelly PW. Compound heterozygosity for mutant hepatic lipase in familial hepatic lipase deficiency. Biochem Biophys Res Commun 1991; 179: 78-84.
29. Hegele RA, Little JA, Vezina C, et al. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 1993; 13: 720-8.
30. Durstenfeld A, Ben-Zeev O, Reue K, et al. Molecular characterization of human hepatic lipase deficiency. In vitro expression of two naturally occurring mutations. Arterioscler Thromb 1994; 14: 381-5.
31. Hegele RA, Tu L Connelly PW. Human hepatic lipase mutations and polymorphisms. Hum Mutat 1992; 1: 320-4.
32. Lipid Research Clinic Population Studies Data Book. The Prevalence study. N.I.H. Publication No. 82.2014 ed. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1982.
33. Emi M, Wilson DE, Iverius P-H, Wu L, et al. Missense mutation (Gly>Glu188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem 1990; 265: 5910-6.
34. Emi M, Hegele RA, Hopkins PN, et al. Effects of three genetic loci in a pedigree with multiple lipoprotein phenotypes. Arterioscler Thromb 1991; 11: 1349-55.
35. Hegele RA, Breckenridge WC, Cox DW, et al. Interaction between variant apolipoproteins C-II and E that affects plasma lipoprotein concentrations. Arterioscler Thromb 1991; 11: 1303-9.
36. Cianflone K, Bilodeau M, Davignon J, et al. Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor. Metabolism 1990; 39: 272-80.
37. Weintraub MS, Eisenberg S Breslow JL. Lovastatin reduces post-prandial lipoprotein levels in hypercholesterolemic patients with mild hypertriglyceridemia. Eur J Clin Invest 1989; 19: 480-5.
38. Huff MW, Sawyez CG, Connelly PW, et al. Beta-VLDL in hepatic lipase deficiency induces apoE-mediated cholesterol ester accumulation in macrophages. Arterioscler Thromb 1993; 13: 1282-90.
39. Connelly PW, Ranganathan S, Maguire GF, et al. The β-very low density lipoprotein present in hepatic lipase deficiency competitively inhibits low density lipoprotein binding to fibroblasts and stimulates fibroblast acylCoA:cholesterol acyltransferase. J Biol Chem 1988; 263: 14184-8.
40. Connelly PW, Maguire GF, Lee M, et al. Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis 1990; 10: 40-8.
41. Shinomiya M, Sasaki N, Barnhart RL, Shirai K, Jackson RL. Effect of apolipoproteins on the hepatic lipase-catalyzed hydrolysis of human plasma high density lipoprotein 2 -triacylglycerols. Biochim Biophys Acta 1982; 713: 292-9.
42. Nozaki S, Kubo M, Sudo H, et al. The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein - postheparin lipolytic activities determined by a sensitive, nonradioisotopic method in hyperlipidemic patients and normals. Metabolism 1986; 35: 53-8.
43. Deleted in proof.
44. Demant T, Carlson LA, Holmquist L, et al. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 1988; 29: 1603-11.
45. Landin B, Nilsson A, Twu JS, et al. A role for hepatic lipase in chylomicron and high density lipoprotein phospholipid metabolism. J Lipid Res 1984; 25: 559-63.
46. Landis BA, Rotolo FS, Meyers WC, et al. Influence of apolipoprotein E on soluble and heparin-immobilized hepatic lipase. Am J Physiol 1987; 252: G805-10.
47. Sultan F, Lagrange D, Le Liepvre X, et al. Chylomicron-remnant uptake by freshly isolated hepatocytes. Effect of heparin and of hepatic triacylglycerol lipase. Biochem J 1989; 258: 587-94.
48. Havel RJ. Chylomicron remnants: hepatic receptors and metabolism. Curr Opin Lipidol 1995; 6: 312-6.
49. Diard P, Malewiak MI, Lagrange D, et al. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem J 1994; 299: 889-94.
50. Weintraub MS, Eisenberg S Breslow JL. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III and type IV hyperlipoproteinemic individuals. J Clin Invest 1987; 79: 1110-9.
51. Rubinstein A, Gibson JC, Paterniti JRJ, et al. Effect of heparin-induced lipolysis on the distribution of apolipoprotein E among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. J Clin Invest 1985; 75: 710-21.
52. Tall AR. Metabolic and genetic control of HDL cholesterol levels. J Intern Med 1992; 231: 661-8.
53. Deckelbaum RJ, Bramkrishnan R, Eisenberg S, et al. Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase. Biochemistry 1992; 31: 8544-51.
54. Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography: particles containing A-I and A-II and particles containing A-I but not A-II. J Biol Chem 1984; 259: 12201-9.
55. 2 subfractions with hepatic lipase. J Lipid Res 1992; 33: 1269-79.
56. Mowri HO, Patsch JR, Ritsch A, et al. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase. J Lipid Res 1994; 35: 291-300.
57. 3 for hepatic lipase. Arterioscler Thromb Vasc Biol 1996; 16: 755-62.
58. Clay MA, Newnham HH Barter PJ. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high-density lipoproteins during incubation in vitro. Arteriosclerosis Thrombosis 1991; 11: 415-22.
59. Hara H, Yokoyama S. Interaction of free apolipoproteins with macrophages. Formation of high-density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem 1991; 266: 3080-6.
60. Cheung AK, Parker CJ, Ren K, et al. Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma. Kidney Int 1996; 49: 1360-71.
61. Rader DJ, Castro G, Zech LA, et al. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I, A-II. J Lipid Res 1991; 32: 1849-59.
62. Jansen H, Hulsman WC. Heparin-releasable (liver) lipase(s) may play a role in the uptake of cholesterol by steroid-secreting tissues. Trends Biochem Sci 1980; 5: 265-8.